Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)
Market Currents

Peregrine Pharmaceuticals' (PPHM) previously reported data for Phase II testing of its...

  • Monday, September 24, 2012, 7:39 AM ET
    Peregrine Pharmaceuticals' (PPHM) previously reported data for Phase II testing of its bavituximab drug is no longer reliable as the company has discovered major discrepancies between some patient sample test results and patient treatment code assignments. Shares remain halted. (PR)
Track new comments on this story

This news story has 10 comments:

  • Last week I decided to raise cash and sold. Did I get lucky on this one - I sold around $4 and $5 and bought around $2 on average. Got nailed on the QCOR thing though........man, bummer.
    24 Sep 2012, 07:42 AM Reply Like
  • This may drop harder than QCOR. If so, batting better than 50%.
    24 Sep 2012, 07:52 AM Reply Like
  • >80% right now. The Hammer of Thor striking there.
    24 Sep 2012, 08:12 AM Reply Like
  • Well...yeah, without that drug, this company's fundamentals are pretty much garbage.

    Expect it to hover in a trading range of $0.40 - $0.90...
    24 Sep 2012, 09:24 AM Reply Like
  • I bought at 0.8 a small position actually. Now being up 70% I am debating on whether I should sell......again.......
    24 Sep 2012, 10:36 AM Reply Like
  • This is crazy - I am making serious money on PPHM by timing correctly and being 100% lucky.......
    24 Sep 2012, 10:37 AM Reply Like
  • Is there anyone who'd rather be smart than lucky?
    24 Sep 2012, 11:21 AM Reply Like
  • Everyone! Unfortunately not easy to accomplish.
    24 Sep 2012, 11:23 AM Reply Like
  • Perfect stock for day trades
    24 Sep 2012, 04:37 PM Reply Like
  • I agree 100%. Too risky right now as investment even though I could take a small gamble position on my gains.
    24 Sep 2012, 07:49 PM Reply Like
Other date
DJIA (DIA) S&P 500 (SPY)